NRT Firms’ Deference To “Informal” FDA Letters In Prop 65 Case Improper

NRT firms' reliance on "unpublished, ad hoc" FDA statements to support their contention that a Proposition 65 warning on OTC smoking cessation products conflicts with federal law is improper, according to a brief filed in California Supreme Court April 15